Progyny PGNY
$35.71 +$0.26 (+0.73%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $35.14 -1.60%
Open$35.52
Prev close$35.45
Day range$35.50 – $36.08
Volume1.11M
Market cap$2.63B
P/E (TTM)32.8
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$341.25M+8.9% YoY
Operating profit$35.18M+63.4% YoY
Net profit$26.25M+89.4% YoY
Diluted EPS$0.32+113.3% YoY
Free cash flow$47.24M+2.7% YoY
Operating cash flow$56.61M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin24.9%
Operating margin9.4%
Net margin6.8%
Return on equity18.7%
Return on assets12.4%
Return on invested capital17.0%
Current ratio1.93
Liabilities / assets38.7%
Cash & investments$195.59M
Total debt$21.73M
Net cash (debt)$173.86M
Free cash flow / sales13.4%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $341.25M | $350.51M | $328.50M | $1.29B | $318.40M |
| Total Operating Revenue | $341.25M | $350.51M | $328.50M | $1.29B | $318.40M |
| Cost of Revenue | $257.51M | $261.21M | $245.43M | $984.18M | $241.52M |
| Gross Profit | $83.74M | $89.30M | $83.07M | $304.48M | $76.88M |
| Operating Expense | $48.56M | $49.30M | $47.69M | $219.21M | $61.66M |
| Selling and Admin Expenses | $48.56M | $49.30M | $47.69M | $219.21M | $61.66M |
| -Selling & Marketing Expense | $18.06M | $18.07M | $16.88M | $72.11M | $17.99M |
| -General & Admin Expense | $30.50M | $31.22M | $30.81M | $147.09M | $43.67M |
| Operating Profit | $35.18M | $40.00M | $35.38M | $85.28M | $15.22M |
| Net Non-Operating Interest Income (Expense) | $1.23M | $1.13M | $1.50M | $10.16M | $2.63M |
| Non-Operating Interest Income | $1.23M | $1.13M | $1.50M | $10.16M | $2.63M |
| Pretax Profit | $36.42M | $41.14M | $36.88M | $95.43M | $17.85M |
| Tax | $10.16M | $13.09M | $12.65M | $36.91M | $5.37M |
| Net Profit | $26.25M | $28.05M | $24.23M | $58.52M | $12.49M |
| Profit from Continuing Operations | $26.25M | $28.05M | $24.23M | $58.52M | $12.49M |
| Net Income to Parent Company | $26.25M | $28.05M | $24.23M | $58.52M | $12.49M |
| Net Income to Common Stockholders | $26.25M | $28.05M | $24.23M | $58.52M | $12.49M |
| Basic EPS | $0.34 | $0.36 | $0.30 | $0.68 | $0.15 |
| Diluted EPS | $0.32 | $0.34 | $0.29 | $0.65 | $0.14 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $675.79M | $715.84M | $698.34M | $742.44M | $742.44M |
| Total Current Assets | $464.40M | $513.02M | $501.55M | $551.78M | $551.78M |
| Cash and Cash Equivalents & Short-Term Investments | $195.59M | $236.93M | $225.11M | $310.10M | $310.10M |
| -Cash and Cash Equivalents | $116.82M | $152.63M | $131.61M | $112.24M | $112.24M |
| -Short Term Investments | $78.77M | $84.29M | $93.50M | $197.86M | $197.86M |
| Receivables | $249.18M | $257.48M | $263.61M | $220.29M | $220.29M |
| -Accounts Receivable | $249.18M | $257.48M | $263.61M | $220.29M | $220.29M |
| Other Current Assets | $19.63M | $18.62M | $12.83M | $21.39M | $21.39M |
| Total Non-Current Assets | $211.39M | $202.82M | $196.79M | $190.66M | $190.66M |
| Net PPE | $73.12M | $65.57M | $59.98M | $54.92M | $54.92M |
| -Gross PPE | $73.12M | $65.57M | $59.98M | $67.26M | $67.26M |
| Goodwill and Other Intangible Assets | $25.36M | $25.60M | $25.85M | $26.19M | $26.19M |
| -Goodwill | $19.83M | $19.85M | $19.88M | $19.98M | $19.98M |
| -Other Intangible Assets | $5.53M | $5.75M | $5.97M | $6.22M | $6.22M |
| Non-Current Deferred Assets | $93.08M | $93.08M | $93.08M | $93.01M | $93.01M |
| Other Non-Current Assets | $19.83M | $18.57M | $17.87M | $16.54M | $16.54M |
| Total Liabilities | $261.77M | $262.58M | $258.99M | $226.39M | $226.39M |
| Total Current Liabilities | $240.04M | $240.08M | $235.74M | $202.39M | $202.39M |
| Payables | $148.00M | $152.05M | $157.83M | $154.03M | $154.03M |
| -Accounts Payable | $148.00M | $152.05M | $157.83M | $124.07M | $124.07M |
| Current Accrued Expenses | $92.04M | $88.03M | $77.92M | $21.16M | $21.16M |
| Total Non-Current Liabilities | $21.73M | $22.50M | $23.25M | $24.00M | $24.00M |
| Long Term Debt and Capital Lease Obligation | $21.73M | $22.50M | $23.25M | $24.00M | $24.00M |
| -Long Term Capital Lease Obligation | $21.73M | $22.50M | $23.25M | $24.00M | $24.00M |
| Total Equity | $414.03M | $453.26M | $439.34M | $516.04M | $516.04M |
| Stockholders' Equity | $414.03M | $453.26M | $439.34M | $516.04M | $516.04M |
| Capital Stock | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 |
| -Common Stock | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 |
| Additional Paid-In Capital | $753.52M | $735.42M | $717.76M | $700.79M | $700.79M |
| Retained Earnings | $281.36M | $255.11M | $227.06M | $202.83M | $202.83M |
| Less: Treasury Stock | -$621.04M | -$537.53M | -$505.76M | -$388.08M | -$388.08M |
| Gains/Losses Not Affecting Retained Earnings | $173,000.00 | $245,000.00 | $277,000.00 | $498,000.00 | $498,000.00 |
| -Accumulated Depreciation | – | – | – | -$12.34M | -$12.34M |
| -Other Payable | – | – | – | $29.95M | $29.95M |
| Short-Term Debt and Capital Lease Obligation | – | – | – | $3.73M | $3.73M |
| -Current Capital Lease Obligation | – | – | – | $3.73M | $3.73M |
| Other Current Liabilities | – | – | – | $1.91M | $1.91M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $56.61M | $50.43M | $45.95M | $210.19M | $54.20M |
| Net cash flow from continuing operations | $56.61M | $50.43M | $45.95M | $210.19M | $54.20M |
| Net Income from Continuing Operations | $26.25M | $28.05M | $24.23M | $58.52M | $12.49M |
| Gain/Loss from Continuing Operations | $131,000.00 | $528,000.00 | $52,000.00 | $79,000.00 | $0.00 |
| Depreciation & Depletion & Amortization | $2.15M | $1.62M | $1.48M | $4.95M | $1.37M |
| Deferred Tax | $9,000.00 | $10,000.00 | $10,000.00 | -$8.12M | -$8.15M |
| Other Non-Cash Items | $154,000.00 | $158,000.00 | $279,000.00 | $434,000.00 | $155,000.00 |
| Change in Working Capital | $2.96M | -$5.58M | -$5.41M | $2.80M | $8.80M |
| -Change in Receivables | $5.23M | $385,000.00 | -$47.77M | -$5.12M | $27.04M |
| -Change in Prepaid Assets | -$997,000.00 | -$5.79M | $9.60M | -$11.95M | $2.91M |
| -Change in Payables and Accrued Expense | -$123,000.00 | $657,000.00 | $35.17M | $29.17M | -$11.81M |
| -Change In Other Working Capital | -$1.15M | -$829,000.00 | -$2.41M | -$9.31M | -$9.35M |
| Net cash flow from investing | -$5.02M | $3.55M | $96.59M | -$159.01M | $8.26M |
| Net Cash Flow from Continuing Investing Activities | -$5.02M | $3.55M | $96.59M | -$159.01M | $8.26M |
| Net PPE Purchase and Sale | -$9.37M | -$6.22M | -$6.35M | -$18.41M | -$5.61M |
| Net Business Purchase and Sale | $0.00 | $0.00 | $0.00 | -$9.34M | $0.00 |
| Net Investment Purchase and Sale | $4.35M | $9.77M | $102.94M | -$131.26M | $13.87M |
| Financing Cash Flow | -$87.40M | -$32.89M | -$123.11M | -$99.36M | -$88.26M |
| Net Cash Flow from Continuing Financing Activities | -$87.40M | -$32.89M | -$123.11M | -$99.36M | -$88.26M |
| Net Common Stock Issuance | -$82.78M | -$30.02M | -$118.61M | -$81.66M | -$81.66M |
| Proceeds from Stock Option Exercised | $392,000.00 | $360,000.00 | $337,000.00 | $1.23M | $426,000.00 |
| Net Other Financing Charges | -$5.02M | -$3.23M | -$4.84M | -$18.94M | -$7.03M |
| Ending Cash Balance | $118.80M | $154.60M | $133.57M | $114.19M | $114.19M |
| Net Change in Cash | -$35.81M | $21.08M | $19.43M | -$48.18M | -$25.80M |
| Beginning Cash Balance | $154.60M | $133.57M | $114.19M | $162.31M | $139.98M |
| Effect of Exchange Rate Changes | $9,000.00 | -$51,000.00 | -$51,000.00 | $62,000.00 | $13,000.00 |
| Free Cash Flow | $47.24M | $44.21M | $39.60M | $191.78M | $48.59M |
No comments yet — be the first to weigh in on PGNY.
Sign in to join the discussion.